UPHL — Uphealth Share Price
0.000.00%
Last trade - 00:00- $7.57m
- $155.78m
- $130.00m
- 39
- 92
- 65
- 72
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 1.69 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.1 | ||
| Price to Tang. Book | 0.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.09 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.26% | ||
| Return on Equity | -67% | ||
| Operating Margin | -39.95% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 5.4 | 123.8 | 158.8 | 130 | 48.8 | 52.3 | 188.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +153.33 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
UpHealth, Inc. is a healthcare technology and technology-enabled service company. The Company operates through three segments: Integrated Care Management, Virtual Care Infrastructure, and Services. The Integrated Care Management segment provides guidance and tools to enhance population health through its SyntraNet platform. This platform improves overall health system performance by leveraging capabilities in data and analytics, health information exchanges, pharmacy care services, health care operations, and population health. The Virtual Care Management leverages digital health tools, technology, data, and analytics to provide telehealth solutions, which use electronic information and telecommunications technologies to support and promote long-distance clinical health care, patient and professional health-related education, and virtual care infrastructure solutions. The Services platform provides behavioral health, mental health, and pharmacy services in the United States.
Directors
- Chirinjeev Kathuria CCH (56)
- Avishay Katz CCH (63)
- Ramesh Balakrishnan CEO (66)
- Martin Beck CFO (55)
- Sabahat Azim CEX (46)
- Azfar Malik CEX
- Darren Derosa CHO
- Ranjani Ramakrishna EVP
- Nashina Asaria CMO
- Edna Johnson CMO
- Jeffery Bray OTH
- Inderjote Kathuria OTH
- Michael Rolla OTH
- Raluca Dinu DRC (42)
- Mariya Pylypiv DRC (32)
- Moshe Bar-Siman-Tov IND (44)
- Nathan Locke IND (38)
- Neil Miotto IND (75)
- Agnes Rey-Giraud IND (56)
- Jerome Ringo IND (66)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- March 6th, 2019
- Public Since
- June 10th, 2019
- No. of Shareholders
- 108
- No. of Employees
- 13
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 18,932,192
- Address
- 14000 S. MILITARY TRAIL, SUITE 203, DELRAY BEACH, 33484
- Web
- https://uphealthinc.com/
- Phone
- +1 3126181322
- Auditors
- BPM LLP
Upcoming Events for UPHL
Q3 2024 UpHealth Inc Earnings Release
Similar to UPHL
1606
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
Advanced Voice Recognition Systems
Pink Sheets on Nasdaq
FAQ
What is the Uphealth share price?
As of Today at 23:56 UTC, shares in Uphealth are trading at $0.44. This share price information is delayed by 15 minutes.
How has the Uphealth share price performed this year?
Shares in Uphealth last closed at $0.44 and the price had moved by -72.5% over the past 365 days. In terms of relative price strength the Uphealth share price has underperformed the S&P500 Index by -76.92% over the past year.
What are the analyst and broker recommendations for Uphealth?
The overall consensus recommendation for Uphealth is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Uphealth dividend yield?
Uphealth does not currently pay a dividend.
Does Uphealth pay a dividend?
Uphealth does not currently pay a dividend.
When does Uphealth next pay dividends?
Uphealth does not currently pay a dividend.
How do I buy Uphealth shares?
To buy shares in Uphealth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Uphealth?
As of the previous close price of $0.44, shares in Uphealth had a market capitalisation of $8.33m.
Where are Uphealth shares listed?
Here are the trading details for Uphealth:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: UPHL
What kind of share is Uphealth?
Based on an overall assessment of its quality, value and momentum Uphealth is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Uphealth share price forecast for 2024?
The analyst consensus target price for shares in Uphealth is $4.00. That is 809.09% above the last closing price of $0.44.
Analysts covering Uphealth currently have a consensus Earnings Per Share (EPS) forecast of $0.15 for the next financial year.
What is the trend in the Uphealth share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Uphealth. Over the past six months, its share price has outperformed the S&P500 Index by +81.53%.
As of the last closing price of $0.44, shares in Uphealth were trading -45.35% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Uphealth PE Ratio?
The Uphealth PE ratio based on its reported earnings over the past 12 months is 1.69. The shares last closed at $0.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Uphealth?
Uphealth's management team is headed by:
- Chirinjeev Kathuria - CCH
- Avishay Katz - CCH
- Ramesh Balakrishnan - CEO
- Martin Beck - CFO
- Sabahat Azim - CEX
- Azfar Malik - CEX
- Darren Derosa - CHO
- Ranjani Ramakrishna - EVP
- Nashina Asaria - CMO
- Edna Johnson - CMO
- Jeffery Bray - OTH
- Inderjote Kathuria - OTH
- Michael Rolla - OTH
- Raluca Dinu - DRC
- Mariya Pylypiv - DRC
- Moshe Bar-Siman-Tov - IND
- Nathan Locke - IND
- Neil Miotto - IND
- Agnes Rey-Giraud - IND
- Jerome Ringo - IND